MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) (LSE:MXC, OTC:MGCLF, ASX:MXC) Roby Zomer joins Proactive to talk about their latest quarter results.
The September and June quarters combined have delivered a record US$2.2mln in cash sales receipts for a consecutive six-month period, with increasing month-on-month sales generated from new key markets including the UK and Ireland.
He say these record sales are a 'good vector of progress' for much stronger quarter ahead.